During the past decade, MBCCOP - Howard University Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MBCCOP - Howard University Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 27 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Eastern Cooperative Oncology Group" with 4 trials sponsored, "Wake Forest University Health Sciences" with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MBCCOP - Howard University Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "MBCCOP - Howard University Cancer Center" are "Lung Cancer" (9 trials), "Breast Cancer" (8 trials), "Head and Neck Cancer" (5 trials), "Colorectal Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "MBCCOP - Howard University Cancer Center" in a lesser frequency.

Most popular intervention types in "MBCCOP - Howard University Cancer Center" are "Drug" (39 trials), "Radiation" (10 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (8 trials), "cisplatin" (7 trials), "gemcitabine hydrochloride" (7 trials), "docetaxel" (5 trials) and "fluorouracil" (5 trials). Other intervention names were less common.

The vast majority of trials in "MBCCOP - Howard University Cancer Center" are 31 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "MBCCOP - Howard University Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in MBCCOP - Howard University Cancer Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in MBCCOP - Howard University Cancer Center, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".